https://www.selleckchem.com/pr....oducts/tubastatin-a.
To investigate risk factors for hernia recurrence, surgical site occurrence/infection (SSO/I) and those requiring procedural intervention (SSOPI) after incisional hernia repair (IHR) following abdominal transplantation. Patients undergoing IHR following abdominal transplant were retrospectively identified in the Americas Hernia Society Quality Collaborative database. Primary outcome measures were SSO/I, SSOPI and hernia recurrence. There was a total of 166 patients. Seventeen patients (10%) had an SSO/I at 30 days. Overall complica